VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BAXBaxter International Inc.
$22.04$11.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBAXBalance Sheet

Baxter International Inc. (BAX) Balance Sheet

30Y historyFree accessUpdated daily

Despite aggressive deleveraging efforts, the company maintains a strained capital structure with a debt-to-equity ratio of 1.61 and goodwill representing 81.6% of total equity as of 2026Q1.

BAX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets6.85B6.87B8.85B9.6B8.01B8.87B8.41B7.5B5.96B7.26B6.57B11.8B10.16B10.2B9.26B8.65B7.99B8.27B7.15B7.55B6.97B5.12B6.02B5.36B5.16B3.98B3.65B3.82B4.29B3.87B3.48B
Cash & Short-Term Investments2.02B1.97B1.76B3.08B1.72B2.95B3.73B3.33B1.84B3.39B2.8B7.36B2.92B2.73B3.27B2.9B2.69B2.79B2.13B2.54B2.48B841M1.11B925M1.17B582M579M606M709M465M761M
Cash Only2.02B1.97B1.76B3.08B1.72B2.95B3.73B3.33B1.84B3.39B2.8B2.21B2.92B2.73B3.27B2.9B2.69B2.79B2.13B2.54B2.48B841M1.11B925M1.17B582M579M606M709M465M761M
Short-Term Investments000000000005.15B0000000000000000000
Accounts Receivable1.7B1.93B1.73B1.77B2.62B2.71B2.08B1.9B1.84B1.79B1.69B1.73B1.88B2.91B2.42B2.42B2.27B2.3B1.98B2.03B1.84B1.77B2.09B1.91B1.84B1.62B1.54B1.65B1.75B1.74B1.49B
Days Sales Outstanding57.8862.7259.3762.4395.281.5364.9560.9160.5161.8360.7363.3864.15112.8863.5163.5864.3766.8958.5365.6664.6465.4580.2678.4682.8380.4884.0494.51111.69120.6999.67
Inventory2.32B2.23B2.05B1.92B2.68B2.45B1.92B1.65B1.67B1.48B1.43B1.6B1.58B3.5B2.8B2.63B2.37B2.56B2.36B2.33B2.07B1.93B2.13B2.1B1.75B1.34B1.16B1.12B1.17B1.21B883M
Days Inventory Outstanding108.33103.58112.27112.73150.25120.5798.6991.495.9788.1186.32100.5693.78243.22150.41140.09125.7154.6138.59148.31133.68122.07139.31155.11147.64124.1116.19126.7151.26171.56119.5
Other Current Assets816M479M2.95B2.51B618M390M342M315M404M368M391M680M3.68B504M344M295M323M226M251M261M231M260M297M140M125M82M371M445M673M458M351M
Total Non-Current Assets13B13.18B16.93B18.68B20.28B24.65B11.61B10.69B9.76B9.85B8.97B9.17B15.98B15.03B11.13B10.42B9.5B9.08B8.26B7.74B7.72B7.61B8.13B8.35B7.32B6.37B5.08B5.83B5.58B4.84B4.12B
Property, Plant & Equipment3.19B3.19B3.18B3.21B5.24B5.81B5.33B5.12B4.53B4.59B4.29B4.39B4.43B7.83B6.1B5.53B5.26B5.16B4.61B4.49B4.23B4.14B4.37B4.59B3.91B3.31B2.81B2.65B2.44B2.36B1.84B
Fixed Asset Turnover3.61x3.53x3.35x3.23x1.92x2.09x2.19x2.22x2.45x2.31x2.37x2.27x2.42x1.20x2.29x2.51x2.44x2.43x2.68x2.51x2.45x2.38x2.18x1.94x2.07x2.23x2.39x2.41x2.33x2.23x2.95x
Goodwill4.9B4.93B5.28B5.79B6.45B9.84B3.22B3.03B3B3.1B2.6B2.69B2.93B4.21B2.5B2.32B2.02B1.82B1.65B1.69B1.62B1.55B000000000
Intangible Assets4.22B4.37B5.22B5.92B6.79B7.79B1.67B1.47B1.41B1.37B1.11B1.35B1.62B2.29B814M826M500M513M390M455M480M494M2.19B2.26B2.02B1.7B1.24B921M930M1.62B1.39B
Long-Term Investments343M103M109M136M247M195M135M76M44M0000000000000000000000
Other Non-Current Assets692M596M2.94B3.36B1.27B642M512M372M292M379M348M390M6.46B657M560M632M586M491M472M418M453M1.42B1.56B1.5B1.39B1.36B1.04B2.25B2.2B855M887M
Total Assets19.85B20.05B25.78B28.28B28.29B33.52B20.02B18.19B15.72B17.11B15.55B20.96B26.14B25.22B20.39B19.07B17.49B17.35B15.4B15.29B14.69B12.73B14.15B13.71B12.48B10.34B8.73B9.64B9.87B8.71B7.6B
Asset Turnover0.55x0.56x0.41x0.37x0.36x0.36x0.58x0.62x0.71x0.62x0.65x0.48x0.41x0.37x0.68x0.73x0.73x0.72x0.80x0.74x0.71x0.77x0.67x0.65x0.65x0.71x0.77x0.66x0.58x0.60x0.72x
Asset Growth %-70.1%-22.21%-8.82%-0.04%-15.61%67.45%10.04%15.73%-8.13%10.07%-25.84%-19.8%3.62%23.71%6.91%9.06%0.78%12.65%0.73%4.14%15.39%-10.04%3.21%9.85%20.64%18.44%-9.45%-2.32%13.39%14.63%-19.51%
Total Current Liabilities3.69B2.97B6.51B6.5B4.75B4.24B3.33B3.23B2.81B2.82B2.74B5.75B6.04B5.25B4.76B4.86B4.04B4.46B3.63B3.81B3.61B4.17B4.29B3.8B3.85B3.29B3.37B2.7B2.83B2.56B2.44B
Accounts Payable1.09B999M968M881M1.11B1.25B1.04B892M998M920M791M716M677M1.1B766M795M745M807M829M920M878M3.24B3.92B3.11B3.04B708M1.99B1.8B2.02B1.96B442M
Days Payables Outstanding46.5246.3653.1151.7862.2561.2453.7349.3257.4654.9647.7544.8940.2676.6741.142.3839.548.7948.6658.4656.81205.52256.1229.06257.4665.52199.49204.92262.34278.7959.82
Short-Term Debt842M84M2.75B2.67B1.4B511M406M541M4M3M3M2.58B1.7B1.04B350M446M24M711M394M425M234M924M361M153M220M201M634M255M271M144M346M
Deferred Revenue (Current)141M141M131M128M154M162M32M000009M760M878M738M635M00000000000000
Other Current Liabilities1.76B1.22B1.53B1.64B618M751M555M584M576M648M744M867M2.04B191M755M895M1.72B482M265M122M000538M588M661M748M640M536M450M1.66B
Current Ratio1.85x2.31x1.36x1.48x1.69x2.09x2.52x2.32x2.12x2.57x2.40x2.05x1.68x1.94x1.95x1.78x1.98x1.85x1.97x1.98x1.93x1.23x1.40x1.41x1.34x1.21x1.08x1.41x1.52x1.51x1.42x
Quick Ratio1.23x1.56x1.05x1.18x1.12x1.52x1.95x1.81x1.53x2.05x1.87x1.77x1.42x1.28x1.36x1.24x1.39x1.28x1.32x1.37x1.36x0.77x0.91x0.86x0.89x0.80x0.74x1.00x1.10x1.04x1.06x
Cash Conversion Cycle119.69119.94118.52123.38183.19140.85109.91102.9999.0294.9999.3119.06117.67279.42172.82161.29150.57172.69148.46155.51141.51-18-36.534.52-26.99139.060.7416.290.6113.47159.36
Total Non-Current Liabilities10.14B10.98B12.25B13.3B17.65B20.16B7.96B7.05B5.04B5.17B4.52B6.35B11.95B11.49B8.65B7.39B6.65B5.47B5.54B4.57B4.8B4.26B6.16B6.63B5.69B3.29B2.7B3.6B4.2B3.53B2.65B
Long-Term Debt8.85B9.68B10.37B11.09B15.23B17.15B5.79B4.81B3.48B3.51B2.78B3.92B7.33B8.13B5.58B4.75B4.36B3.44B3.36B2.66B2.57B2.41B3.93B4.42B4.4B2.49B1.73B2.6B3.1B2.63B1.7B
Capital Lease Obligations679M244M243M265M447M522M501M510M000000000000000029M000000
Deferred Tax Liabilities245M245M103M403M661M962M143M192M215M280M93M195M0000000000000218M160M311M461M316M255M
Other Non-Current Liabilities1.29B783M1.49B1.51B1.27B1.45B1.5B1.49B1.34B1.39B1.65B2.23B4.61B3.36B3.07B2.64B2.29B2.03B2.18B1.9B2.24B1.85B2.22B2.21B1.26B588M816M684M646M580M697M
Total Liabilities13.83B13.95B18.76B19.81B22.39B24.4B11.29B10.28B7.85B8B7.27B12.1B17.98B16.74B13.41B12.24B10.69B9.93B9.18B8.38B8.41B8.43B10.44B10.43B9.54B6.59B6.07B6.3B7.03B6.09B5.09B
Total Debt9.69B10B13.45B14.11B17.2B18.31B6.8B5.96B3.48B3.51B2.78B6.51B9.03B9.17B5.93B5.2B4.39B4.15B3.76B3.09B2.8B3.34B4.29B4.57B4.65B2.69B2.36B2.86B3.37B2.78B2.04B
Net Debt7.67B8.04B11.69B11.04B15.48B15.36B3.07B2.63B1.65B118M-19M4.29B6.1B6.43B2.66B2.29B1.7B1.36B1.63B550M316M2.5B3.19B3.65B3.48B2.1B1.78B2.25B2.66B2.31B1.28B
Debt / Equity1.61x1.64x1.91x1.67x2.92x2.01x0.78x0.75x0.44x0.39x0.34x0.73x1.11x1.08x0.85x0.76x0.65x0.56x0.60x0.45x0.45x0.78x1.16x1.40x1.58x0.72x0.89x0.85x1.19x1.06x0.82x
Debt / EBITDA14.44x14.86x13.30x8.35x-8.26x2.79x2.33x1.48x1.72x1.80x5.39x6.24x8.10x1.68x1.44x1.56x1.18x1.18x1.12x1.16x1.50x2.87x2.54x2.36x1.63x1.65x1.88x2.48x2.31x1.62x
Net Debt / EBITDA11.43x11.94x11.56x6.53x-6.93x1.26x1.03x0.70x0.06x-0.01x3.55x4.22x5.69x0.75x0.63x0.60x0.39x0.51x0.20x0.13x1.13x2.13x2.02x1.77x1.28x1.25x1.48x1.96x1.92x1.02x
Interest Coverage-0.83x-0.74x0.29x1.48x-6.86x6.39x9.44x9.74x18.39x13.94x56.66x3.93x3.93x3.42x26.12x31.53x17.43x24.37x17.64x18.05x18.23x12.97x14.53x13.87x24.20x13.92x10.08x-5.26x-4.26x
Total Equity6.02B6.1B7.02B8.47B5.89B9.12B8.73B7.91B7.87B9.12B8.28B8.87B8.16B8.49B6.98B6.83B6.8B7.42B6.23B6.92B6.27B4.3B3.71B3.27B2.94B3.76B2.66B3.35B2.84B2.62B2.5B
Equity Growth %-42.39%-13.13%-17.05%43.65%-35.37%4.53%10.29%0.58%-13.71%10.1%-6.6%8.69%-3.89%21.61%2.2%0.47%-8.41%19.12%-9.93%10.27%45.89%16.03%13.16%11.4%-21.77%41.29%-20.58%17.93%8.4%4.59%-32.4%
Book Value per Share11.6811.8913.7716.7411.7017.9516.8815.2414.4116.4315.0316.1514.9115.4612.5511.9211.4412.089.7810.579.566.836.005.676.336.694.495.674.914.644.54
Total Shareholders' Equity6.04B6.13B6.96B8.4B5.83B9.08B8.69B7.88B7.84B9.12B8.29B8.85B8.12B8.46B6.94B6.58B6.57B7.19B6.23B6.92B6.27B4.3B3.71B3.27B2.94B3.76B2.66B3.35B2.84B2.62B2.5B
Common Stock683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M648M648M649M627M609M298M294M291M00
Retained Earnings13.69B13.71B14.93B16.11B14.05B17.07B16.33B15.72B15.07B14.48B14.2B9.68B13.23B11.85B10.89B9.43B7.92B7.34B5.79B4.38B3.27B2.85B2.26B2.15B1.69B1.09B853M1.42B990M1.01B1.02B
Treasury Stock0-10.87B-11.06B-11.23B-11.39B-11.49B-11.05B-10.76B-9.99B-7.98B-8B-7.65B-7.99B-7.91B-7.59B-6.72B-5.66B-4.74B-3.9B-2.5B-1.43B-1.15B-1.51B-1.86B-1.33B-328M-349M-269M-210M00
Accumulated OCI-3.8B-3.75B-4.01B-3.55B-3.83B-3.38B-3.31B-3.71B-3.82B-4B-4.56B224M-3.65B-1.98B-2.81B-2.59B-2.14B-1.78B-1.89B-940M-1.43B-1.5B-1.29B-1.43B-1.27B-432M-649M-374M-296M00
Minority Interest-27M-27M60M66M62M44M37M30M22M-8M-10M19M36M23M40M243M229M229M0000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

High leverage and restructuring

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Contraction Amidst Restructuring

As reported in recent financial filings, Baxter's total assets have declined from $28.3 billion in 2023Q4 to $19.8 billion by 2026Q1, reflecting a deliberate, albeit aggressive, reduction in the company's asset base as it navigates the complex divestiture of its Renal Care business.

The consistent downward trend in total assets suggests that the company is actively shedding legacy operations to streamline its portfolio. Investors should monitor whether this contraction successfully improves capital efficiency or if it merely leaves the remaining entity with a diminished competitive footprint.

Leverage Remains Elevated Despite Deleveraging

Based on quarterly balance sheet data, Baxter's total debt has decreased from $14.1 billion in 2023Q4 to $9.7 billion in 2026Q1, yet the debt-to-equity ratio remains elevated at 1.61, indicating that the company's financial flexibility continues to be constrained by its prior acquisition-heavy strategy.

While the absolute debt reduction is a positive step, the persistent D/E ratio suggests that the company remains highly leveraged relative to its current equity base. This leverage profile may limit the firm's ability to pursue further strategic initiatives until the Vantive separation is fully realized and debt is further retired.

Liquidity Buffers Show Inconsistent Trends

According to recent SEC filings, Baxter's current ratio has fluctuated significantly, moving from 1.48 in 2023Q4 to a peak of 2.31 in 2025Q4 before settling at 1.85 in 2026Q1, highlighting the volatility in working capital management during this period of intense organizational transformation.

The variability in the current ratio suggests that the company's short-term liquidity position is highly sensitive to the timing of restructuring-related cash outflows and inventory adjustments. This lack of stability warrants caution, as it may indicate difficulty in maintaining a predictable cash buffer for operational contingencies.

Goodwill and Intangibles Risk Exposure

As evidenced by the provided financial statements, Baxter carries $4.9 billion in goodwill as of 2026Q1, which represents a significant portion of the company's $6.0 billion in total equity, signaling a potential vulnerability to future impairment charges if the acquired businesses underperform expectations.

The high concentration of goodwill relative to equity suggests that the balance sheet is sensitive to valuation adjustments, particularly given the ongoing portfolio transformation. Investors should consider the risk that future strategic shifts or poor performance in the Hillrom-integrated segments could necessitate non-cash write-downs that would further erode the equity base.

BAX — Frequently Asked Questions

Quick answers to the most common questions about buying BAX stock.

What are the total assets of Baxter International Inc. (BAX)?

As of 2025, Baxter International Inc. (BAX) had total assets of $20.05B including $6.87B in current assets.

How much debt does Baxter International Inc. (BAX) have?

Baxter International Inc. (BAX) carries total debt of $10.00B, offset by $1.97B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Baxter International Inc.?

Baxter International Inc. (BAX) has total shareholders' equity (book value) of $6.13B ($11.89 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Baxter International Inc.'s current ratio and liquidity?

Baxter International Inc. (BAX) reported a current ratio of 2.31x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.